Items where Author is "Morgan, R"
|Up a level|
Morgan, R, Bryan, RT, Javed, S, Launchbury, F, Zeegers, MP, Cheng, KK, James, ND, Wallace, DM, Hurst, CD, Ward, DG, Knowles, MA and Pandha, H (2013) Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker. Eur J Cancer. ISSN 0959-8049
Alharbi, RA, Pettengell, R, Pandha, HS and Morgan, R (2012) The role of HOX genes in normal hematopoiesis and acute leukemia. Leukemia. ISSN 0887-6924
Morgan, R, Boxall, A, Harrington, K, Simpson, G, Gillett, C, Michael, A and Pandha, H (2012) Targeting the HOX / PBX dimer in breast cancer Breast Cancer Research and Treatment.
Morgan, R, Boxall, A, Bhatt, A, Bailey, M, Hindley, R, Langley, S, Whitaker, HC, Neal, DE, Ismail, M, Whitaker, H, Annels, N, Michael, A and Pandha, H (2011) Engrailed-2 (EN2): A Tumor Specific Urinary Biomarker for the Early Diagnosis of Prostate Cancer CLINICAL CANCER RESEARCH, 17 (5). 1090 - 1098. ISSN 1078-0432
Heinemann, L, Simpson, GR, Boxall, A, Kottke, T, Relph, KL, Vile, R, Melcher, A, Prestwich, R, Harrington, KJ, Morgan, R and Pandha, HS (2011) Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer. BMC Cancer, 11. 221 - ?. ISSN 1471-2407
Morgan, R, Plowright, L, Harrington, KJ, Michael, A and Pandha, HS (2010) Targeting HOX and PBX transcription factors in ovarian cancer BMC CANCER, 10. ? - ?. ISSN 1471-2407
Pandha, HS, Heinemann, L, Simpson, GR, Melcher, A, Prestwich, R, Errington, F, Coffey, M, Harrington, KJ and Morgan, R (2009) Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma CLINICAL CANCER RESEARCH, 15 (19). 6158 - 6166. ISSN 1078-0432
Morgan, R and Whiting, K (2008) Differential expression of HOX genes upon activation of leukocyte sub-populations INTERNATIONAL JOURNAL OF HEMATOLOGY, 87 (3). 246 - 249. ISSN 0925-5710
Morgan, R, Fairfax, B and Pandha, HS (2006) Calcium insensitivity of FA-6, a cell line derived from a pancreatic cancer associated with humoral hypercalcemia, is mediated by the significantly reduced expression of the Calcium Sensitive Receptor transduction component p38 MAPK MOLECULAR CANCER, 5. ? - ?. ISSN 1476-4598